Pfizer profit tops estimates, books $11 billion tax gain

(Reuters) – Pfizer Inc beat analysts’ estimate for adjusted profit on Tuesday, helped by strong demand for its pneumonia vaccine Prevnar and breast cancer drug Ibrance, while also reporting an $11 billion gain from the new tax law.


Source: Reuters

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>